Current status and perspectives of immune-based therapies for hepatocellular carcinoma
about
Immunotherapeutic approaches for hepatocellular carcinomaIs Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 PatientsFrequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.Systemic treatment for hepatocellular carcinoma: Still unmet expectationsSurface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activationDual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies.Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.B lymphocytes repress hepatic tumorigenesis but not development in Hras12V transgenic mice.MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer.Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology
P2860
Q33779723-7AE9D345-A4FF-430B-A09B-4F357D5A8C86Q36231664-B94DEAF9-EF37-4B9E-9720-BD194DCEF516Q39006737-09A99B4A-44E0-4F5F-A16C-93104342154AQ39112745-0111A713-E90D-4CF2-A3A8-48607F3C50D5Q40160910-2EF89440-0489-4A92-9AB5-53DA68C8541BQ42702294-B694CA16-7D11-476D-BD90-A37202B26A41Q47098282-9150612F-2E27-4815-83A1-47B14CB8C4AFQ47998524-E2795299-70CC-483B-ADAC-B453FB32065BQ48330501-989721BA-6269-4623-BFDD-42662E97D47BQ52595263-9021B2AB-1BB0-4F83-B6E6-2B93F926989CQ59129137-1D3FCBD2-16F9-4ACE-8F63-191B9028F46C
P2860
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@ast
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@en
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@nl
type
label
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@ast
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@en
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@nl
prefLabel
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@ast
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@en
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@nl
P2093
P2860
P356
P1476
Current status and perspectives of immune-based therapies for hepatocellular carcinoma
@en
P2093
Daphné Benteyn
Hans Van Vlierberghe
Kris Thielemans
Maridi Aerts
P2860
P304
P356
10.3748/WJG.V22.I1.253
P407
P577
2016-01-01T00:00:00Z